Invention Grant
- Patent Title: Imidazotriazinone compounds
- Patent Title (中): 咪唑三嗪酮化合物
-
Application No.: US14334073Application Date: 2014-07-17
-
Publication No.: US09540380B2Publication Date: 2017-01-10
- Inventor: Richard Chesworth , Gerhard Koenig , Amy Ripka , Gideon Shapiro
- Applicant: Ironwood Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Ironwood Pharmaceuticals, Inc.
- Current Assignee: Ironwood Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Andrej Barbic
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/53
Abstract:
The present invention provides imidazotriazinone compounds which are inhibitors of phosphodiesterase 9. The present invention further provides processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of PDE9 associated diseases or disorders in mammals, including humans.
Public/Granted literature
- US20140330014A1 IMIDAZOTRIAZINONE COMPOUNDS Public/Granted day:2014-11-06
Information query
